Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma

Liver cancer is the fourth most common cause of cancer‐related death worldwide, with hepatocellular carcinoma (HCC) being the main primary malignancy affecting the liver. Unfortunately, there are still limited therapeutic options for HCC, and even the latest advances have only increased the overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulero‐Sánchez, Antonio, Ramirez, Christel F. A., du Chatinier, Aimée, Wang, Hui, Koomen, Sofie J. I., Song, Ji‐Ying, de Groot, Marnix H. P., Lieftink, Cor, Bosma, Astrid, Burylo, Artur, van Tellingen, Olaf, Beijersbergen, Roderick L., Wang, Cun, Akkari, Leila, Bernards, René, Mainardi, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257427/
https://www.ncbi.nlm.nih.gov/pubmed/36650715
http://dx.doi.org/10.1002/1878-0261.13377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257427/
https://www.ncbi.nlm.nih.gov/pubmed/36650715
http://dx.doi.org/10.1002/1878-0261.13377

Ejemplares similares